Israeli specialty chemicals organization ICL (TASE: ICL: NYSE: ICL), controlled by Idan Ofer, has noted very strong success for the 1st quarter of 2022, boosted by the bounce in commodity price ranges around the world. The company has also elevated its steerage for 2022.

ICL’s profits in the very first quarter of 2022 was $2.525 billion, up 67% from $1.510 billion in the corresponding quarter of 2021. Web gain in the initially quarter of 2022 was $632 million, up 368% from the to start with quarter of 2021. Adjusted EBITDA of $1.002 billion was up 232% from $302 million in the initial quarter of 2021.




Associated Content




Israel Corp. sells ICL shares for $220m



ICL results in being most valuable TASE company



Sanctions on Belarus to increase ICL potash product sales



ICL indications increased-priced Chinese potash agreements







ICL president and CEO Raviv Zoller said, “ICL shipped file final results, even with worldwide uncertainty, and leveraged its agility and range in the encounter of continuing supply chain challenges. As soon as yet again, all our specialty organizations achieved new quarterly benefits data, as all 4 of our divisions contributed to our sizeable expansion and new ICL history product sales and EBITDA.

He included, “We continued to concentrate on long phrase cash era by innovating inside of our specialty companies item portfolio and by driving charge efficiencies. The disruptions prompted by the pandemic, sanctions and the conflict in Ukraine have radically shifted market dynamics and could keep on to drastically effects global agriculture, food stuff and industrial markets in the near time period. We will continue on to enhance our buyer and provider interactions, to manage by means of global provide problems and to perform to make sure consistent and responsible item offer for our clients.”

ICL said that thanks to the quite strong effects in the first quarter, and major improvements in industry dynamics, the company is increasing its expectations for entire year adjusted EBITDA to a assortment of $3.5 billion to $3.750 billion, with in between $1.300 billion to $1.400 billion coming from its specialties focused businesses.

ICL’s share price rose 2.60% to $10.26 on Wall Street final night, giving a industry cap of $13.66 billion. The share cost is up a even more 2.34% in premarket buying and selling.

Printed by Globes, Israel company news – en.globes.co.il – on Could 11, 2022.

© Copyright of Globes Publisher Itonut (1983) Ltd., 2022.


